The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical.
Lifestyle
Evaluation of the Long-term Effect of Integrated Lifestyle Treatments on Dietary Habits, Sedentary Behavior, Anthropometry, Quality of Life in Female Breast Cancer Survivors, Through Traditional and Innovative Statistical Methods.
1 other identifier
observational
112
1 country
1
Brief Summary
The goal of this observational-retrospective study is to learn about the long-term effects of a lifestyle intervention inclusive of dietary counselling and physical activity advice, on body weight in female breast cancer survivors who took the intervention in previous years compared to those who did not take it. The main question it aims to answer is: Does a long-term lifestyle intervention help to control body weight 5 years after breast cancer diagnosis? Participants are asked to answer online survey questions about their anthropomethry, clinical conditions, socio-economical status, dietary habits, physical activity levels, quality of life, sleep quality and pshycological distress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 4, 2023
CompletedFirst Submitted
Initial submission to the registry
February 19, 2025
CompletedFirst Posted
Study publicly available on registry
March 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 10, 2025
January 1, 2025
3.3 years
February 19, 2025
March 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Measurement of body weight in kilograms
The primary objective of the study is to evaluate whether an integrated lifestyle cancer treatment (L-INT) with nutritional and physical activity counseling, within the first year of diagnosis of histologically confirmed primary breast cancer, can result in better control of body weight (measured as BMI classes) after 5 years from diagnosis compared to those who had not adhered to integrated lifestyle treatments (no-INT).
Baseline
Measurement of body height in meters
The primary objective of the study is to evaluate whether an integrated lifestyle cancer treatment (L-INT) with nutritional and physical activity counseling, within the first year of diagnosis of histologically confirmed primary breast cancer, can result in better control of body weight (measured as BMI classes) after 5 years from diagnosis compared to those who had not adhered to integrated lifestyle treatments (no-INT).
Baseline
Secondary Outcomes (4)
Units on a Scale adherence to the Mediterranean diet.
Baseline
Units on a Scale moderate physical activity.
Baseline
Units on a Scale the microbiome of breast tissue
Baseline
Units on a Scale of questionnaries quality of life
Baseline
Study Arms (1)
Lifestyle
The cohort incluedes women (N=428) with a 5-year primary diagnosis of breast cancer eligible to participate in a diet and exercise trial (DEDiCa) in the previous years. Half of them actively participated in the trial and half did not for reasons other than health related issues. Those who consent to participate to the current observational study completed a series of questionnaires.
Interventions
Participants are asked to answer online survey questions about their anthropomethry, clinical conditions, socio-economical status, dietary habits, physical activity levels, quality of life, sleep quality and pshycological distress.
Eligibility Criteria
Women with a 5-year diagnosis of breast cancer, living in Italy and followed up in the participating hospitals.
You may qualify if:
- Surgery for primary breast cancer performed at least 5 years prior to the interview.
- Women who have joined the DEDiCa trial or who have refused to participate for reasons not related to serious health conditions or disease progression.
- Those who are able to sign the informed consent.
You may not qualify if:
- Age \<30 years.
- Primary diagnosis of metastatic breast cancer.
- Diagnosis of other malignancies prior to the diagnosis of breast cancer.
- Those who are unable to sign the informed consent or who deny to be contacted by telephone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Cancer Institute Foundation G. Pascale of Naples
Naples, 80131, Italy
Biospecimen
An exploratory secondary objective of the study, in a subset of the sample (N=40), includes an investigation of the microbiome of the breast tissue extracted during breast cancer surgery. This analysis is useful to determine breast cancer tissue microbiome and potential associations with different lifestyle.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nutrition Researcher, PhD S.C. Epidemiologia e Biostatistica
Study Record Dates
First Submitted
February 19, 2025
First Posted
March 10, 2025
Study Start
September 4, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 10, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share